1. Molecular mechanisms of EBV-driven cell cycle progression and oncogenesis
   Huali Yin et al, 2019, Medical Microbiology and Immunology CrossRef
2. Expression of LMP and EBNA genes in Epstein-Barr virus-associated lymphomas in Hu-PBL/SCID mice
   YUNLIAN TANG et al, 2016, Oncology Reports CrossRef
3. Epigenetics of Epstein Barr virus — A review
   Gadde Shareena et al, 2023, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
4. Microorganisms in Pathogenesis and Management of Sjögren’s Syndrome
   Luca Di Bartolomeo et al, 2022, Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases CrossRef
5. Infectious mononucleosis in children and differences in biomarker levels and other features between disease caused by Epstein–Barr virus and other pathogens: a single-center retrospective study in China
   Yangcan Ming et al, 2023, PeerJ CrossRef
6. Designer nucleases to treat malignant cancers driven by viral oncogenes
   Tristan A. Scott et al, 2021, Virology Journal CrossRef
7. Identification of IgH gene rearrangement and immunophenotype in an animal model of Epstein–Barr virus‐associated lymphomas
   Yang Zhang et al, 2016, Journal of Medical Virology CrossRef
8. Epstein–Barr Virus—Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies
   Marcus Bauer et al, 2021, Cancers CrossRef
9. Multifunctional role of exosomes in viral diseases: From transmission to diagnosis and therapy
   Pinal Chaudhari et al, 2022, Cellular Signalling CrossRef
10. Rapamycin enhances lytic replication of Epstein-Barr virus in gastric carcinoma cells by increasing the transcriptional activities of immediate-early lytic promoters
    Man Wang et al, 2018, Virus Research CrossRef
11. Bioinformatic analysis of differentially expressed genes and identification of key genes in EBV-transformed lymphoblasts
    Yunlian Tang et al, 2019, Biomedicine & Pharmacotherapy CrossRef